Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 24/2/2020
SIETES contiene 92915 citas

<< anterior 21 a 40 de 2731 siguiente >>
Presentar resultados
Seleccionar todas
23.Tiene citas relacionadas
Moorthy VS, Okwo-Bele J-M. Final results from a pivotal phase 3 malaria vaccine trial. Lancet 2015;386:5-7. [Ref.ID 99327]
24. Cita con resumen
Kesselheim AS, Campbell EG, Schneeweiss S, Rausch P, Lappin BM, Zhou EH, Seeger JD, Brownstein JS, Woloshin S, Schwartz LM, Toomey T, Dal Pan GJ, Avorn J. Methodological approaches to evaluate the impact of FDA drug safety communications. Drug Saf 2015;38:565-75. [Ref.ID 99239]
25. Cita con resumen
Althabe F, Bellizán JM, McClure EM, Hemmingway-Foday J, Berrueta M, Mazzoni A, Ciganda A, Goudar SS, Kodkany BS, Mahantshetti NS, Dhaded SM, Katageri GM, Metgud MC, Joshi AM, Bellad MB, Honnungar NV, Derman RJ, Saleem S, Pasha O, Ali S, Hasnain F, Goldenberg RL, Esamai F, Nyongesa P, Ayunga S, Liechty EA, Garces AL, Figueroa L, Hambidge KM, Krebs NF, Patel A. A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Lancet 2015;385:629-39. [Ref.ID 98799]
26. Cita con resumen
John J, Giri S, Karthikeyan AS, Iturriza-Gomara M, Muliyil J, Abraham A, Grassly NC, Kang G. Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial. Lancet 2014;384:1505-12. [Ref.ID 98251]
27. Cita con resumen
Anónimo. Miltefosine (Impavido) for leishmaniasis. Med Lett Drugs Ther 2014;56:89-90. [Ref.ID 98224]
28. Cita con resumen
Anónimo. Drugmakers banking on Ebola drug, vaccine stockpiling. DIA Daily 2014:27 de octubre. [Ref.ID 98201]
29.Enlace a cita original
Arie S. Ebola: an opportunity for a clinical trial?. BMJ 2014;349:g4997. [Ref.ID 98180]
30. Cita con resumen
Friedrich MJ. Potential therapies and vaccines to combat Ebola. JAMA 2014;312:1503. [Ref.ID 98160]
31. Cita con resumen
Bagcchi S. Indian generic drugs debate heats up. Lancet 2014;384:1334. [Ref.ID 98157]
32. Cita con resumen
Capeding MR, Tran NH, Hadinegoro SRS, Ismail HIHJM, Chotpitayasunondh T, Chua MN, Luong CQ, Rusmil K, Wirawan DN, Nallusamy R, Pitisuttithum P, Thisyakom U, Yoon I-K, van der Vliet D, Langevin E, Laot T, Hutagalung Y, Frago C, Boaz M, Wartel TA, Tornieporth NG, Saville M, Bouckenooghe A, the CYD14 Study Group. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. Lancet 2014;384:1358-65. [Ref.ID 98156]
33. Cita con resumen
Anónimo. Drug manufacturers race to cure Ebola. DIA Daily 2014:20 de octubre. [Ref.ID 98121]
35. Cita con resumen
Anónimo. Gilead in pact to sell cheaper version of Sovaldi In developing countries. DIA Daily 2014:16 de septiembre. [Ref.ID 97898]
36.Enlace a cita original
Anónimo. Heart failure: gaps in knowledge and failures in treatment . PLOS Medicine 2014;11:e1001702. [Ref.ID 97870]
38. Cita con resumen
Jayasekera CR, Barry M, Roberts LR, Nguyen MH. Treating hepatitis C in lower-income countries. N Engl J Med 2014;370:1869-71. [Ref.ID 97602]
39. Cita con resumen
Steinhoff MC, MacDonald N, Pfeifer D, Muglia LJ. Influenza vaccine in pregnancy: policy and research strategies. Lancet 2014;383:1611-3. [Ref.ID 97591]
40. Cita con resumen
Pietersen E, Ignatius E, Streicher EM, Mastrapa B, Padanilam X, Pooran A, Badri M, Lesosky M, van Helden P, Sirgel FA, Warren R, Dheda K. Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study. Lancet 2014;383:1230-9. [Ref.ID 97376]
Seleccionar todas
<< anterior 21 a 40 de 2731 siguiente >>